# Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer

> **NCT03028311** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 12 (estimated)

## Conditions studied

- Metastatic Liver Carcinoma
- Stage IV Liver Cancer
- Stage IVA Liver Cancer
- Stage IVB Liver Cancer

## Interventions

- **PROCEDURE:** Angiography
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Planar Imaging
- **RADIATION:** Radioembolization
- **PROCEDURE:** Single Photon Emission Computed Tomography
- **RADIATION:** Technetium Tc-99m Albumin Aggregated
- **OTHER:** Yttrium Y 90 Resin Microspheres

## Key facts

- **NCT ID:** NCT03028311
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-01-09
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03028311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03028311, "Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03028311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*